EKSO Logo

Ekso Bionics Holdings, Inc. (EKSO) 

NASDAQ
Market Cap
$15.4M
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
523 of 774
Rank in Industry
33 of 48

Largest Insider Buys in Sector

EKSO Stock Price History Chart

EKSO Stock Performance

About Ekso Bionics Holdings, Inc.

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also …

Insider Activity of Ekso Bionics Holdings, Inc.

Over the last 12 months, insiders at Ekso Bionics Holdings, Inc. have bought $0 and sold $0 worth of Ekso Bionics Holdings, Inc. stock.

On average, over the past 5 years, insiders at Ekso Bionics Holdings, Inc. have bought $15,477 and sold $156,770 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 4,032 shares for transaction amount of $5,005 was made by Lathan Corinna (director) on 2023‑11‑02.

List of Insider Buy and Sell Transactions, Ekso Bionics Holdings, Inc.

2023-11-02Purchasedirector
4,032
0.0281%
$1.24$5,005+8.87%
2023-08-23Purchasedirector
5,500
0.0402%
$0.95$5,222+42.40%
2023-08-17SalePresident & COO
37,446
0.2868%
$1.00$37,281+35.35%
2023-08-17SaleChief Financial Officer
12,784
0.0979%
$1.00$12,728+35.35%
2023-08-10Purchasedirector
4,201
0.0332%
$1.25$5,251+14.10%
2023-05-24SaleExecutive Chair
45,660
0.3393%
$1.44$65,874-6.85%
2023-05-08SaleChief Operating Officer
3,435
0.0259%
$1.57$5,401-12.74%
2022-12-04SaleExecutive Chair
10,576
0.084%
$1.28$13,492
2022-11-21SaleCEO & Chairman
5,787
0.0421%
$1.26$7,312+3.79%
2022-11-16SaleSenior VP Product Development
782
0.0059%
$1.28$1,003+6.01%
2022-11-16SaleChief Financial Officer
723
0.0055%
$1.28$927+6.01%
2022-10-24SaleCEO & Chairman
5,921
0.0449%
$1.29$7,619+6.98%
2022-08-31SaleSenior VP Product Development
5,873
0.0442%
$2.31$13,587-38.94%
2022-08-21SaleCEO & Chairman
5,572
0.0412%
$2.20$12,278
2022-08-03SaleInterimChief Financial Officer
1,675
0.0127%
$1.80$3,021-19.23%
2022-07-21SaleCEO & Chairman
5,662
0.0412%
$1.75$9,909-19.02%
2022-07-18SaleInterimChief Financial Officer
98
0.0007%
$1.71$167-13.29%
2022-06-30SalePresident & COO
4,997
0.0399%
$1.72$8,595-5.45%
2022-06-21SaleCEO & Chairman
5,330
0.0418%
$1.74$9,259-8.72%
2022-06-15SaleCEO & Chairman
6,911
0.0542%
$1.90$13,118-15.96%

Insider Historical Profitability

17.59%
SHERMAN STEVENExecutive Chair
364913
1.6588%
$0.70112+32.03%
Lathan Corinnadirector
147990
0.6727%
$0.7030
Peurach JackChief Executive Officer
78120
0.3551%
$0.7011+39.84%
SCHEDER-BIESCHIN MAXChief Financial Officer
32371
0.1472%
$0.7020+1.86%
Looby ThomasPresident & CEO
20315
0.0923%
$0.7020+3.84%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Kent Lake Capital LLC$810,628.003.28596,050+322.26%+$618,653.120.37
The Vanguard Group$776,771.003.14571,155+30.72%+$182,552.85<0.0001
Geode Capital Management$150,137.000.61110,349+12.08%+$16,182.56<0.0001
Renaissance Technologies$111,000.000.4581,716+2.13%+$2,309.22<0.0001
BlackRock$74,459.000.354,749-1.27%-$957.45<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.